pharma · Advanced Solid Tumors · Non-Hodgkin's Lymphoma
Liposome Company
Taiwan Liposome Company
Taiwan Liposome Company is a pharma organization headquartered in CN. Primary therapeutic focus areas include Advanced Solid Tumors, Non-Hodgkin's Lymphoma, Safety Issues, HepatoCellular Carcinoma, Cognitive Function. No
CN HQ
21 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 21
- Programs
- 6
- Drugs
- 7
- Patents
- 0
Cyclophosphamide Doxorubicin Vincristine Lamivudine
Phase 2 · small molecule · Non-Hodgkin's Lymphoma
Cyclophosphamide Doxorubicin Vincristine Lamivudine for Non-Hodgkin's Lymphoma is a Phase 2 program (small_molecule) at Taiwan Liposome Company with 1 ClinicalTrials.gov record(s).
Internal code T1401
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Taiwan Liposome Company
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Non-Hodgkin's Lymphoma
- Status
- completed
- Trials
- 1